Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
9.01
0.21 (2.39%)
At close: Aug 19, 2025, 1:47 PM
2.39% (1D)
| Bid | 8.91 |
| Market Cap | 426.2M |
| Revenue (ttm) | -11.61M |
| Net Income (ttm) | -68.13M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -5.33 |
| Forward PE | 738 |
| Analyst | Buy |
| Ask | 9.14 |
| Volume | 37,410 |
| Avg. Volume (20D) | 7,738 |
| Open | 9.00 |
| Previous Close | 8.80 |
| Day's Range | 8.79 - 9.10 |
| 52-Week Range | 2.76 - 9.10 |
| Beta | 1.50 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
7 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.
